Skip to main content
2024 PharmSci 360 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back

Michael Lowinger, PhD (he/him/his)

Executive Director
Merck & Co., Inc.
Rahway, New Jersey

Michael Lowinger, Ph.D. is currently the Executive Director of Merck’s Formulation, Laboratory and Experimentation (FLEx) Center, an industry-leading network of drug product development and clinical supply facilities. He joined the Pharmaceutical Sciences organization at Merck in 2004, focused on various aspects of drug product design and development. Through the progression of various roles, Mike has overseen the development of over two dozen compounds from early Discovery target validation through late-stage process development and commercialization, including three approved drug products and several in late stage development. Mike served as area lead for Merck’s oral product HIV development pipeline, covering 8 development molecules and several combination products. He previously led the Materials and Biophysical Characterization team, driving process and product understanding across Merck’s entire pipeline through innovative materials science and biophysical characterization solutions.

Mike completed his doctoral dissertation in Molecular Pharmaceutics and Drug Delivery from the University of Texas at Austin, where he studied sustained release drug delivery applications of poly(urethanes). He previously obtained his M.S. in Pharmaceutical Science at Temple University and his B.S. in Chemical Engineering at the University of Delaware. Mike has authored or co-authored 24 publications and is an inventor of 3 patents and one patent application.

Disclosure information not submitted.

Presentation(s):